Page last updated: 2024-10-17

aminocaproic acid and Endocarditis

aminocaproic acid has been researched along with Endocarditis in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Endocarditis: Inflammation of the inner lining of the heart (ENDOCARDIUM), the continuous membrane lining the four chambers and HEART VALVES. It is often caused by microorganisms including bacteria, viruses, fungi, and rickettsiae. Left untreated, endocarditis can damage heart valves and become life-threatening.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhou, Z1
Ye, J1
Teng, J1
Liu, H1
Cheng, X1
Sun, Y1
Su, Y1
Chi, H1
Wang, F1
Yang, C1
Jin, W1

Other Studies

1 other study available for aminocaproic acid and Endocarditis

ArticleYear
Clinical characteristics of infective endocarditis in patients with antineutrophil cytoplasmic antibody or antiphospholipid antibody: a retrospective study in Shanghai.
    BMJ open, 2020, 02-12, Volume: 10, Issue:2

    Topics: Aminocaproic Acid; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Antiphospholipid; Blood Sedim

2020